Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Aim/hypothesis This study aimed to investigate if variability in the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with Type II (non-insulin-dependent) diabetes mellitus.Methods The PGC-1 gene was examined in 53 Type II diabetic patients applying single strand conformational polymorphism analysis followed by nucleotide sequencing. Identified variants were genotyped in an association study comprising 483 Type II diabetic patients and 216 glucose-tolerant control subjects. A replication study was done in an additional 201 Type II diabetic patients and 293 glucose-tolerant subjects. Furthermore, a potential interaction between the Pro12Ala polymorphism of PPAR-gamma2 and the PGC-1 Gly482Ser variant on risk of Type II diabetes was investigated.Results A total of seven variants (Ser74Leu, IVS2 + 52C-->A, Thr394Thr, Asp475Asp, Gly482Ser, Thr528Thr, and Thr612Met) were identified and investigated in an association study. Six of the variants showed no association with Type II diabetes in the initial study. However, the Gly482Ser polymorphism, was more frequent among Type II diabetic patients (37.0 %) than among glucose-tolerant subjects (30.8 %) (p = 0.032). In a replication study the difference in allele frequencies of the Gly482Ser variant remained significant (p = 0.0135). The combined study yielded an allele frequency of 37.3 % (34.7-39.9) for Type II diabetic patients and 30.5 % (27.7-33.4) for glucose-tolerant subjects (p = 0.0007). No interaction between this variant and the Pro12Ala polymorphism of PPAR-gamma2 was observed.Conclusion/interpretation A widespread Gly482Ser polymorphism of PGC-1 is associated with a 1.34 genotype relative risk of Type II diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Transcriptional analysis reveals that expression of PGC-1α target genes is coordinately down-regulated in human diabetics [84, 85] and PGC-1α genetic polymorphisms have been linked to Type II Diabetes [104, 105].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195
Michael, L. F., Wu, Z., Cheatham, R. B., Puigserver, P., Adelmant, G., Lehman, J. J., Kelly, D. P., & Spiegelman, B. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061035098 · Cited by 663
The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 Diabetes
Hara, K., Okada, T., Tobe, K., Yasuda, K., Mori, Y., Kadowaki, H., Hagura, R., Akanuma, Y., Kimura, S., Ito, C., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2605 · Cited by 273
Hani, E. H., Boutin, P., Durand, E., Inoue, H., Permutt, M. A., Velho, G., & Froguel, P. (1998) · Diabetologia · doi:10.1007/s001250051098 · Cited by 264
Mori, H., Ikegami, H., Kawaguchi, Y., Seino, S., Yokoi, N., Takeda, J., Inoue, I., Seino, Y., Yasuda, K., Hanafusa, T., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.4.891 · Cited by 238
Cited by
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
“Type II diabetes has also been associated with a Pro121A polymorphism in the PPARγ gene (5) and with a Gly482Ser polymorphism in the PGC-1 gene in Danish (53) and Pima Indian (156) populations.”
BackgroundType 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
“Importantly, a single nucleotide polymorphism (Gly482Ser) in human PGC-1α has been associated with insulin resistance and susceptibility to type 2 diabetes in some populations (Ek et al., 2001; Hara et al., 2002; Lacquemant et al., 2002; Muller et al., 2003).”
BackgroundPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Islet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Cantó, C., & Auwerx, J. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328328d0a4 · Cited by 1,624
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,432
Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030101 · Cited by 951
Transcriptional Regulatory Elements in the Human Genome
Maston, G. A., Evans, S. K., & Green, M. R. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115623 · Cited by 937
Schreiber, S. N., Emter, R., Hock, M. B., Knutti, D., Cardenas, J., Podvinec, M., Oakeley, E. J., & Kralli, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308686101 · Cited by 658
Nuclear Receptor Coregulators: Judges, Juries, and Executioners of Cellular Regulation
Lonard, D. M., & O'Malley, B. W. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.012 · Cited by 494
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion
Ling, C., Del Guerra, S., Lupi, R., Rönn, T., Granhall, C., Luthman, H., Masiello, P., Marchetti, P., Groop, L., & Del Prato, S. (2008) · Diabetologia · doi:10.1007/s00125-007-0916-5 · Cited by 495
“Furthermore, a common polymorphism, Gly482Ser, in the PPARGC1A gene has been associated with increased risk of type 2 diabetes and an age-related reduction in muscle PPARGC1A expression [3–5].”
BackgroundBefroy, D. E., Petersen, K. F., Dufour, S., Mason, G. F., de Graaf, R. A., Rothman, D. L., & Shulman, G. I. (2007) · Diabetes · doi:10.2337/db06-0783 · Cited by 453
Pessayre, D., & Fromenty, B. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.004 · Cited by 441
Villena, J. A. (2015) · The FEBS Journal · doi:10.1111/febs.13175 · Cited by 405
The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
Bouché, C., Serdy, S., Kahn, C. R., & Goldfine, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0026 · Cited by 346
The Inherited Basis of Diabetes Mellitus: Implications for the Genetic Analysis of Complex Traits
Florez, J. C., Hirschhorn, J., & Altshuler, D. (2003) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.4.070802.110436 · Cited by 329
Barroso, I., Luan, J., Middelberg, R. P. S., Harding, A.-H., Franks, P. W., Jakes, R. W., Clayton, D., Schafer, A. J., O'Rahilly, S., & Wareham, N. J. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000020 · Cited by 321
Nuclear Receptor Coregulators and Human Disease
Lonard, D. M., Lanz, R. B., & O’Malley, B. W. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0012 · Cited by 302
Parkinson's disease, insulin resistance and novel agents of neuroprotection
Aviles-Olmos, I., Limousin, P., Lees, A., & Foltynie, T. (2013) · Brain · doi:10.1093/brain/aws009 · Cited by 283
“Indeed polymorphisms in PGC1 have been associated with an increased risk for type 2 diabetes mellitus in diverse populations (Ek et al., 2001; Hara et al., 2002; Bhat et al., 2007).”
BackgroundDevelopment of insulin resistance in mice lacking PGC-1α in adipose tissues
Kleiner, S., Mepani, R. J., Laznik, D., Ye, L., Jurczak, M. J., Jornayvaz, F. R., Estall, J. L., Chatterjee Bhowmick, D., Shulman, G. I., & Spiegelman, B. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207287109 · Cited by 287
“A Gly482Ser allele of PGC-1α has been associated with an increased risk of type 2 diabetes in both Danish (47) and Asian Indian (48) subjects.”
BackgroundFinck, B. N., & Kelly, D. P. (2007) · Circulation · doi:10.1161/circulationaha.107.670588 · Cited by 282
Nuclear receptor coregulators: modulators of pathology and therapeutic targets
Lonard, D. M., & O'Malley, B. W. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.100 · Cited by 272
Role of mitochondria in non‐alcoholic fatty liver disease
Pessayre, D. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04640.x · Cited by 279
Barroso, I. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01550.x · Cited by 268
Silander, K., Mohlke, K. L., Scott, L. J., Peck, E. C., Hollstein, P., Skol, A. D., Jackson, A. U., Deloukas, P., Hunt, S., Stavrides, G., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1141 · Cited by 267
Ling, C., Poulsen, P., Carlsson, E., Ridderstråle, M., Almgren, P., Wojtaszewski, J., Beck-Nielsen, H., Groop, L., & Vaag, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21889 · Cited by 300
Brown adipose tissue and thermogenesis
Fenzl, A., & Kiefer, F. W. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0022 · Cited by 225
PGC-1 coactivators in the control of energy metabolism
Liu, C., & Lin, J. D. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr007 · Cited by 210
The Epigenetic Basis of Twin Discordance in Age-Related Diseases
Poulsen, P., Esteller, M., Vaag, A., & Fraga, M. F. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e31803c7b98 · Cited by 213
“However, some studies have demonstrated associations between various metabolic defects underlying the development of type 2 diabetes and polymorphisms in several susceptibility genes, such as PPAR (6), PGC-1 (7), and, most recently, TCF7L2 (8).”
Suwa, M., Egashira, T., Nakano, H., Sasaki, H., & Kumagai, S. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00255.2006 · Cited by 210
“PGC-1 is associated with insulin sensitivity and Type 2 diabetes (8, 15, 27, 31, 35).”
Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes
Zorzano, A., Liesa, M., & Palacín, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.02.004 · Cited by 209
Eichner, L. J., & Giguère, V. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.03.121 · Cited by 198
Ribel-Madsen, R., Fraga, M. F., Jacobsen, S., Bork-Jensen, J., Lara, E., Calvanese, V., Fernandez, A. F., Friedrichsen, M., Vind, B. F., Højlund, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051302 · Cited by 202
“These candidate genes were CDKN2A, DUSP9, HNF4A, HHEX, KCNQ1, KLF11, PPARGC1A and SLC30A8 in muscle and ADCY5, CAV1, CIDEC, CDKN2A, CDKN2B, DUSP9, HNF4A, IDE, IRS1, KCNQ1, MTNR1B, TSPAN8 and WFS1 in SAT.”
BackgroundInfluentialPPAR control: it's SIRTainly as easy as PGC
Sugden, M. C., Caton, P. W., & Holness, M. J. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0359 · Cited by 192
Ling, C., Poulsen, P., Simonsson, S., Rönn, T., Holmkvist, J., Almgren, P., Hagert, P., Nilsson, E., Mabey, A. G., Nilsson, P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30938 · Cited by 189
Hypothalamic PGC-1α Protects Against High-Fat Diet Exposure by Regulating ERα
Morselli, E., Fuente-Martin, E., Finan, B., Kim, M., Frank, A., Garcia-Caceres, C., Navas, C. R., Gordillo, R., Neinast, M., Kalainayakan, S. P., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.025 · Cited by 187
“, 2004), and that polymorphisms of the PGC-1α gene correlate with increased risk of type 2 diabetes (Ek et al., 2001), findings that Morselli et al.”
BackgroundErkens, T., Van Poucke, M., Vandesompele, J., Goossens, K., Van Zeveren, A., & Peelman, L. J. (2006) · BMC Biotechnology · doi:10.1186/1472-6750-6-41 · Cited by 183
Expanding functional diversity of the coactivators
Lonard, D. M., & O'Malley, B. W. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.001 · Cited by 172
Robitaille, J., & Grant, A. M. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31816b8710 · Cited by 163
Poulsen, P., Levin, K., Petersen, I., Christensen, K., Beck-Nielsen, H., & Vaag, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.275 · Cited by 166
Jiang, W. G., Douglas‐Jones, A., & Mansel, R. E. (2003) · International Journal of Cancer · doi:10.1002/ijc.11302 · Cited by 162
PGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
Loktionov, A. S. (2003) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(03)00032-9 · Cited by 175
“Peroxisome proliferatoractivated receptorgamma-coactivator-1 (PGC-1) gene At least eight polymorphisms [140,141].”
BackgroundPGC-1α, glucose metabolism and type 2 diabetes mellitus
Wu, H., Deng, X., Shi, Y., Su, Y., Wei, J., & Duan, H. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0021 · Cited by 167
The Genetic Basis of Type 2 Diabetes.
Das, S. K., & Elbein, S. C. (2006) · PubMed · doi:10.1901/jaba.2006.2-100 · Cited by 152
Weikard, R., Kühn, C., Goldammer, T., Freyer, G., & Schwerin, M. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00103.2004 · Cited by 171
Roden, M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803102 · Cited by 149
PGC-1α: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes
Soyal, S. M., Krempler, F., Oberkofler, H., & Patsch, W. (2006) · Diabetologia · doi:10.1007/s00125-006-0268-6 · Cited by 161
Muller, Y. L., Bogardus, C., Pedersen, O., & Baier, L. (2003) · Diabetes · doi:10.2337/diabetes.52.3.895 · Cited by 142
Self-citationStefan, N., Thamer, C., Staiger, H., Machicao, F., Machann, J., Schick, F., Venter, C., Niess, A., Laakso, M., Fritsche, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1785 · Cited by 139
“The Gly482Ser amino acid exchange in the PGC1 gene (PPARGC1A) is associated with type 2 diabetes (18, 19) and physical fitness (20).”
BackgroundPPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men
Lucia, A., Gómez-Gallego, F., Barroso, I., Rabadán, M., Bandrés, F., San Juan, A. F., Chicharro, J. L., Ekelund, U., Brage, S., Earnest, C. P., et al. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00037.2005 · Cited by 131
“Several studies have reported an increased frequency of the Ser482 allele in Type 2 diabetic patients (9, 15, 24).”
BackgroundResultBioenergetics, the origins of complexity, and the ascent of man
Wallace, D. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914635107 · Cited by 141
“…of such variants in human populations include polymorphisms in the nDNA-encoded mitochondrial uncoupling protein genes (30 – 33) and in the bioenergetic transcription factor genes for the peroxisome-proliferator-activated receptor γ (PPAR γ ) (34) and PPAR γ -coactivator 1 α (PCG-1 α ) (35, 36).”
Wallace, D. C. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0267 · Cited by 141
Bioenergetic Origins of Complexity and Disease
Wallace, D. C. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010462 · Cited by 124
“A Pro121Ala polymorphism in the PPARg has been associated with Type II diabetes (Altshuler et al. 2000), and a Gly482Ser polymorphism in the PGC-1a gene has been associated with Type II diabetes in Danish populations (Ek et al. 2001) and in Pima Indians (Muller et al. 2003).”
BackgroundAndrulionyt�, L., Zacharova, J., Chiasson, J. L., Laakso, M., & for the STOP-NIDDM Study Group (2004) · Diabetologia · doi:10.1007/s00125-004-1577-2 · Cited by 133
“In our study no statistically significant interaction which may lead to an increase in the conversion to type 2 diabetes was found between the polymorphisms of the PPAR-γ2 and PGC-1α genes, this is in accord with the results of a previous study among Danish subjects [38].”
BackgroundResultInfluentialMeta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes
Barroso, I., Luan, J., Sandhu, M. S., Franks, P. W., Crowley, V., Schafer, A. J., O’Rahilly, S., & Wareham, N. J. (2006) · Diabetologia · doi:10.1007/s00125-005-0130-2 · Cited by 130
“Specifically, a common PPARGC1A polymorphism, Gly482Ser, has been studied for association with type 2 diabetes with conflicting results [8–12].”
BackgroundKim, K., Kim, K. H., Kim, H. H., & Cheong, J. (2008) · Biochemical Journal · doi:10.1042/bj20081336 · Cited by 110
Mitochondrial dysfunction in pancreatic β-cells in Type 2 Diabetes
Mulder, H., & Ling, C. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.05.015 · Cited by 128
“…of PGC-1α are associated with Type 2 Diabetes and with indices of β-cell function in some, but not all, studies performed (Barroso et al., 2006; Ek et al., 2001; Hara et al., 2002; Lacquemant et al., 2002; Muller et al., 2003; Oberkofler et al., 2004; Sun et al., 2006; Vimaleswaran et l.,…”
BackgroundJoseph, A.-M., Pilegaard, H., Litvintsev, A., Leick, L., & Hood, D. A. (2006) · Essays in Biochemistry · doi:10.1042/bse0420013 · Cited by 111
Kojima, T., Kamei, H., Aizu, T., Arai, Y., Takayama, M., Nakazawa, S., Ebihara, Y., Inagaki, H., Masui, Y., Gondo, Y., et al. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.05.007 · Cited by 125
McCarthy, M. I. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh057 · Cited by 110
Vimaleswaran, K. S., Radha, V., Ghosh, S., Majumder, P. P., Deepa, R., Babu, H. N. S., Rao, M. R. S., & Mohan, V. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01709.x · Cited by 111
Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Gene Locus
Esterbauer, H., Oberkofler, H., Linnemayr, V., Iglseder, B., Hedegger, M., Wolfsgruber, P., Paulweber, B., Fastner, G., Krempler, F., & Patsch, W. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1281 · Cited by 106
OBERKOFLER, H., SCHRAML, E., KREMPLER, F., & PATSCH, W. (2003) · Biochemical Journal · doi:10.1042/bj20021665 · Cited by 100
Genetic approaches to the molecular understanding of type 2 diabetes
McCarthy, M. I., & Froguel, P. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00099.2002 · Cited by 103
“34fold relative risk of T2D (28), although there is no indication of interaction with the PPAR Pro12Ala variant.”
BackgroundLudovico, O., Pellegrini, F., Paola, R. D., Minenna, A., Mastroianno, S., Cardellini, M., Marini, M. A., Andreozzi, F., Vaccaro, O., Sesti, G., et al. (2007) · Obesity · doi:10.1038/oby.2007.617 · Cited by 106
Oberkofler, H., Linnemayr, V., Weitgasser, R., Klein, K., Xie, M., Iglseder, B., Krempler, F., Paulweber, B., & Patsch, W. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1385 · Cited by 96
“Associations of the 1564 site with type 2 diabetes have been reported in a Danish population (13), but these results are at variance with studies in French and H.”
ResultCandidate Genes for Type 2 Diabetes
Parikh, H. M., & Groop, L. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000021437.46773.26 · Cited by 102
The pathogenetic role of β-cell mitochondria in type 2 diabetes
Fex, M., Nicholas, L. M., Vishnu, N., Medina, A., Sharoyko, V. V., Nicholls, D. G., Spégel, P., & Mulder, H. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0367 · Cited by 102
Do PPARGC1A and PPARα polymorphisms influence sprint or endurance phenotypes?
Eynon, N., Meckel, Y., Sagiv, M. S., Yamin, C., Amir, R. E., Sagiv, M. S., Goldhammer, E., Duarte, J. A., & de Oliveira, J. J. F. (2010) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2009.00930.x · Cited by 107
“The Ser482 allele of the PPARGC1A gene was previously associated with type 2 diabetes (Ek et al., 2001; Hara et al., 2002), whereas the Gly482 allele has been associated with beneficial effects such as alteration of lipid oxidation and early insulin secretion (Muller et al., 2003).”
BackgroundEpigenetic changes in diabetes
Keating, S., & El‐Osta, A. (2013) · Clinical Genetics · doi:10.1111/cge.12121 · Cited by 86
“Expression of this gene is linked with islet insulin secretion and a recently described polymorphism in the coding region is associated with increased risk for T2DM (113).”
Metabolic roles of PGC-1α and its implications for type 2 diabetes
Besseiche, A., Riveline, J., Gautier, J., Bréant, B., & Blondeau, B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.02.002 · Cited by 96
“[124] Ek J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, Borch-”
BackgroundA Decreased Mitochondrial DNA Content Is Related to Insulin Resistance in Adolescents
Gianotti, T. F., Sookoian, S. C., Dieuzeide, G., García, S. I., Gemma, C., González, C. D., & Pirola, C. J. (2008) · Obesity · doi:10.1038/oby.2008.253 · Cited by 86
Srensen, T. I. A., Boutin, P., Taylor, M. A., Larsen, L. H., Verdich, C., Petersen, L., Holst, C., Echwald, S. M., Dina, C., Toubro, S., et al. (2006) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0010012 · Cited by 78
Self-citationTimmons, J. A., Norrbom, J., Schéele, C., Thonberg, H., Wahlestedt, C., & Tesch, P. (2006) · Genomics · doi:10.1016/j.ygeno.2005.09.007 · Cited by 79
“Two large transcriptome analysis studies [16,20] followed on from epidemiological evidence that genetic variation in PGC-1a is related to the development of Type 2 diabetes [3].”
BackgroundThePPARGC1Agene Gly482Ser in Polish and Russian athletes
Maciejewska, A., Sawczuk, M., Cięszczyk, P., Mozhayskaya, I. A., & Ahmetov, I. I. (2011) · Journal of Sports Sciences · doi:10.1080/02640414.2011.623709 · Cited by 88
Moreno, M., Lombardi, A., Silvestri, E., Senese, R., Cioffi, F., Goglia, F., Lanni, A., & de Lange, P. (2010) · PPAR Research · doi:10.1155/2010/435689 · Cited by 87
“Although at least two clinical studies have identified a correlation between mutations of the gene encoding PGC-1α and either insulin resistance or diabetes [69, 70], basic research has produced contrasting results.”
ResultBeck‐Nielsen, H., Vaag, A. A., Poulsen, P., & Gaster, M. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(03)00041-1 · Cited by 87
Oberkofler, H., Esterbauer, H., Linnemayr, V., Strosberg, A. D., Krempler, F., & Patsch, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200475200 · Cited by 76
Yoneda, M., Hotta, K., Nozaki, Y., Endo, H., Uchiyama, T., Mawatari, H., Iida, H., Kato, S., Hosono, K., Fujita, K., et al. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-27 · Cited by 80
PPARGC1A Variation Associated With DNA Damage, Diabetes, and Cardiovascular Diseases
Lai, C.-Q., Tucker, K. L., Parnell, L. D., Adiconis, X., García-Bailo, B., Griffith, J., Meydani, M., & Ordovás, J. M. (2008) · Diabetes · doi:10.2337/db07-1238 · Cited by 76
Ridderstråle, M., Johansson, L. E., Råstam, L., & Lindblad, U. (2006) · Diabetologia · doi:10.1007/s00125-005-0129-8 · Cited by 76
“The genotype distribution of the PPARGC1A Gly482Ser polymorphism found here was similar to that observed in other studies [5, 6, 10, 12].”
ResultAndrulionytė, L., Peltola, P., Chiasson, J., Laakso, M., & for the STOP-NIDDM Study Group (2006) · Diabetes · doi:10.2337/db05-1629 · Cited by 72
“The Gly482Ser substitution of PGC-1A has been linked to increased risk of diabetes (15,20), but no association of SNPs of PPARD with diabetes has been reported.”
BackgroundOliveira, R. L. G. S., Ueno, M., de Souza, C. T., Pereira-da-Silva, M., Gasparetti, A. L., Bezzera, R. M. N., Alberici, L. C., Vercesi, A. E., Saad, M. J. A., & Velloso, L. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00103.2004 · Cited by 65
“Accordingly, at least two clinical studies have found a correlation between mutations of the PGC-1 gene and insulin resistance or diabetes (8, 13).”
BackgroundHsieh, M., Lin, K., Tien, K., Tu, S., Hsiao, J., Chang, S., Lin, S., Shing, S.-J., & Chen, H. (2010) · Metabolism · doi:10.1016/j.metabol.2009.10.030 · Cited by 68
Andrulionytė, L., Kuulasmaa, T., Chiasson, J., Laakso, M., & for the STOP-NIDDM Study Group (2007) · Diabetes · doi:10.2337/db06-1110 · Cited by 64
Perspective: The Search for Genes for Type 2 Diabetes in the Post-Genome Era
Elbein, S. C. (2002) · Endocrinology · doi:10.1210/endo.143.6.8831 · Cited by 70
“(G482S) of the PPAR coactivator-1 gene was reported to be associated with T2DM in Danish Caucasians (48).”
BackgroundBhat, A., Koul, A., Rai, E., Sharma, S., Dhar, M. K., & Bamezai, R. N. K. (2007) · Human Genetics · doi:10.1007/s00439-007-0352-0 · Cited by 68
“…e-mail: bamezai@hotmail.com A. Bhat · A. Koul · M. K. Dhar Department of Biotechnology, University of Jammu, Jammu, India between PGC1A gene variants and T2DM (Ek et al. 2001; Hara et al. 2002; Barroso et al. 2006) as well as reduced insulin sensitivity in obese Caucasian subjects with PGC1A…”
BackgroundLeslie, R. D., & Cohen, R. M. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300403 · Cited by 67
Oropeza, D., Jouvet, N., Bouyakdan, K., Perron, G., Ringuette, L., Philipson, L. H., Kiss, R. S., Poitout, V., Alquier, T., & Estall, J. L. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.08.001 · Cited by 68
Genetics of type 2 diabetes mellitus: status and perspectives
Hansen, L. B., & Pedersen, O. B. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00396.x · Cited by 68
Self-citationMitochondria, Bioenergetics, and the Epigenome in Eukaryotic and Human Evolution
Wallace, D. C. (2009) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2009.74.031 · Cited by 64
“For example, polymorphisms in peroxisome proliferation-activated receptor γ (PPARγ) (Alt - shuler et al. 2000) and PGC-1α (Ek et al. 2001; Muller et al. 2003) genes have been associated with regional predilection to diabetes.”
BackgroundInfluentialWirtenberger, M., Tchatchou, S., Hemminki, K., Schmutzhard, J., Sutter, C., Schmutzler, R., Meindl, A., Wappenschmidt, B., Kiechle, M. B., Arnold, N., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl067 · Cited by 65
Oberkofler, H., Klein, K., Felder, T. K., Krempler, F., & Patsch, W. (2006) · Endocrinology · doi:10.1210/en.2005-0817 · Cited by 59
Obesidad, adipogénesis y resistencia a la insulina
Pérez, M. R., & Medina‐Gómez, G. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.05.008 · Cited by 91
Obesity, adipogenesis and insulin resistance
Pérez, M. R., & Medina‐Gómez, G. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2011.05.004 · Cited by 67
The common PPAR-γ2 Pro12Ala variant is associated with greater insulin sensitivity
Buzzetti, R., Petrone, A., Ribaudo, M. C., Alemanno, I., Zavarella, S., Mein, C. A., Maiani, F., Tiberti, C., Baroni, M. G., Vecci, E., et al. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201283 · Cited by 66
Metadata
- Authors
- Ek, J., Andersen, G., Urhammer, S. A., Gæde, P. H., Drivsholm, T., Borch-Johnsen, K., Hansen, T., & Pedersen, O.
- Affiliations
- Glostrup Hospital (DK)
- Venue
- Diabetologia
- Published
- 2001-12-01
- Volume
- 44
- Issue
- 12
- Pages
- 2220-2226
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1984668213
- Cited by
- 293
- References
- 19
- Citations by year
- 2026: 2 · 2025: 4 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 8 · 2016: 3 · 2015: 11 · 2014: 7 · 2013: 12 · 2012: 15
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Funders
- Velux Stiftung
- Hjerteforeningen
- Sundhed og Sygdom, Det Frie Forskningsråd
- Diabetesforeningen
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- PGC-1, type 2 diabetes, Gly482Ser polymorphism, genetic association, genotype relative risk, amino acid polymorphism, genetic susceptibility to diabetes
- MeSH terms
- Aged, Alleles, Amino Acid Sequence, Diabetes Mellitus, Type 2, DNA Mutational Analysis, Female, Gene Frequency, Genotype, Humans, Male, Middle Aged, Polymorphism, Genetic, Transcription Factors, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.